1 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Butyrates: new trials by email Literature Review of Butyrates trials Research Report on Butyrates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients PLL001 or placebo daily subcutaneous injections - Amyotrophic Lateral Sclerosis, ALS | Phase 1 / Phase 2 | Not yet recruiting | PLL TX AUSTRALIA PTY LTD | 153 | 2026-04-08 | 2026-03-19 |
| Butyrate Adjuvant Therapy for Type 1 Diabetes BKR-017 - Type1diabetes | Phase 1 / Phase 2 | Completed | Mayo Clinic | 6 | 2022-07-28 | 2026-03-31 |
Amyotrophic Lateral Sclerosis (1)
Mayo Clinic (1) · PLL TX AUSTRALIA PTY LTD (1)
United States (1)
Adrian Vella, MD (1) · Tina Soulis (1)